It should not be given to children or teenagers with or recovering from viral illnesses due to Reye's syndrome risk
"No FDA-approved applications pursuant to section 505 of the FD&C Act, 21 U.S.C
Still to be determined is whether this gain of function is the result of changes in the structure or the function of the gastrointestinal microbial community
As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
Because of this, synthetic HGH injections are only indicated for severe health conditions (e.g., AIDS, Turner Syndrome, and adult-onset HGH deficiency)
![PDF] Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial](https://figures.semanticscholar.org/898978c1b0543b943d605e293f5296fb7568cee7/9-Table2-1.png)
